Search

Stability of pemetrexed disodium

Antibiotic infusion

“The aim of this study was to assess the stability of pemetrexed disodium (Alimta), reconstituted in 100 mL sodium chloride 0.9% w/v intravenous infusion bags (Baxter Viaflo)” Nelson et al (2021).

IV tubing residual volume

IV medication

“An unrecognized phenomenon across the antimicrobial landscape may be residual volume remaining within intravenous tubing, never getting to the patient” Peyko (2021).

Subclavian CVC training – Full Text

chlorhexidine allergy

“To develop and implement a comprehensive program to train providers to place subclavian central venous catheters (CVCs) using real-time ultrasound guidance” Davis et al (2021).

RAVESTO tool for complex vascular access patients

peripheral iv

“The tool we describe (RAVESTO-Rapid Assessment of Vascular Exit Site and Tunneling Options) defines the different options of subcutaneous tunneling and their indications in different clinical situations in patients with complex vascular access” Ostroff et al (2021).

PICC UEDVT risk factors

catheter-related candidemia

“Among the common risk factors, local risk factors reflecting peripherally inserted central catheter technology itself had a greater effect than systemic risk factors reflecting predisposition to thrombosis” Chen et al (2021).

PICC complications in newborns

neonatal ultrasound

“The aim of this systematic review (SR) is to estimate the prevalence of complications associated with the use of PICC in NBs” Sarmento Diniz et al (2021).

Vascular access curriculum for student nurses

Vascular access guide

“An innovative vascular access and infusion nursing (VAIN) curriculum was created and mapped onto the entry to practice undergraduate nursing program at McGill University in Montréal, Québec, Canada” Marchionni et al (2021).

Peripheral IV complications

Infusion

“The aim of this descriptive and cross-sectional study was to determine the knowledge and practices of nurses related to the prevention of peripheral intravenous therapy (PIT) complications, and to identify the influencing factors” Yilmaz et al (2021).

Central venous access device training

Implantable port

“The new education programme was introduced to all registered nurses working in one care group within an acute healthcare Trust with the aim of improving knowledge and skills and reduce CVAD-related complications” Burt and Spowart (2021)

Taurolidine catheter lock solution

IV flush

“A solution containing 2% taurolidine seems suitable as a hemodialysis catheter lock. In a Swiss cohort, it prevented CRBSI, limited catheter dysfunction, and was cost-efficient” Neusser et al (2021).

UK vessel health and preservation framework

OPAT

“In 2016, a UK vessel health and preservation (VHP) framework was developed to support healthcare staff to select the most appropriate vascular access device for patients requiring intravenous therapy” Hallam et al (2021).

Extravasation injury treatment – Full Text

PICC

“The treatment of severe extravasation injuries using a combination of localized closure, ethacridine lactate dressing, and phototherapy resulted in satisfactory outcomes in patients” Lu et al (2021).

Integrated short peripheral cannula

clabsi

“A rapid review of the current evidence suggests that this new device may have different clinical performance and different indications if compared to standard short peripheral cannulas” Pinelli and Pittiruti (2021).

IV flushing with pre-filled syringes

opat

“This article describes how one large university health board in Wales implemented a change in products and practice and explores the issues around adopting and using CE-marked pre-filled, sterile syringes of 0.9% sodium chloride in place of manually drawing up an IV flush (the CE mark indicates devices that conforms with European legal requirements)” Lee and Terry (2021).

Peripheral IV care – Full Text

Peripheral IV

“Our main objective was to assess the feasibility and inter-rater agreement on the PIVC-mini Questionnaire (PIVC-miniQ) in a tertiary care hospital in Nepal” Shrestha et al (2021).

Vascular access patient experience

VIP Score

“Having a CVAD affects the psychological, social, and personal self and impacts on self-esteem and self-image” Kelly and Snowden (2021).

Meropenem pharmacokinetics in sepsis

IV Port

“A prospective single-center study assessed whether fluid retention alters meropenem pharmacokinetics and the achievement of the pharmacokinetic/pharmacodynamic (PK/PD) targets for efficacy” Pařízková et al (2021).

CVC ultrasound placement training

Ultrasound

“Although the learning curve for CVC ultrasound placement is usually fast, formal training and certification for beginners are strongly recommended” Forneris et al (2021).

IV antibiotic administration rate

Antibiotic infusion

“The rapid administration of intravenous ceftriaxone, ertapenem, meropenem and daptomycin in an outpatient setting is clinically safe and well tolerated” Ling et al (2021).

Ultrasound-guided CVC placement

Ultrasound

“Although not superior to the standard internal jugular approach, the novel supraclavicular approach proved to be a noninferior method for central venous cannulation” Aydın et al (2021).

PICC for patients with moyamoya disease

clabsi

“We report the successful use of PICC in children undergoing surgery for moyamoya disease with a considerable success rate and low incidence of malpositioning or complications” Ji et al (2021).

Continuous versus intermittent infusion of antibiotics

IVTEAM Antibiotic infusion

“The aim of this review was to perform a critical reappraisal of the real-world evidence supporting administration by prolonged infusion of novel beta-lactams for the management of multidrug-resistant Gram-negative infections” Gatti and Pea (2021).

CVC removal complication – Full Text

Intracavity ECG

“In patients with hematological malignancy and CVC-associated UE-DVT, early removal of CVCs was not associated with an increased risk of PE compared with delayed or no removal” Houghton et al (2021).

CLABSI antibiotic treatment duration

chlorhexidine allergy

“Recent data suggest that administration of appropriate antibiotic therapy for 7 days or less may be as well tolerated and effective as longer courses in episodes of GNB-CRBSI, once the CVC has been removed” Ruiz-Ruigómez and Aguado (2021).

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey